ArticlePediatric cardiology2026
Anomalous Origin of a Pulmonary Artery from the Aorta: Prognosis, Risk Factors and Long-Term Outcomes.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To summarize the surgical treatment experience and long-term outcomes of patients with anomalous origin of one pulmonary artery from the ascending aorta (AOPA). From December 2009 to December 2022, 76 patients undergoing surgical treatment for AOPA in our hospital were enrolled. Two different reimplantation methods were used to correct the anomaly, including direct anastomosis in 45 (group A) and angioplasty with autologous tissue in 31 patients (group B). Early and late outcomes were compared between the two groups, and the independent risk factors for aberrant pulmonary artery(aPA) restenosis were determined. The median age at repair was 90 (8-1211) days. Hospital death occurred in two patients. During the follow-up period, there was no all-cause death. One patient in group A was lost to follow-up. Freedom from postoperative aPA restenosis at 1, 5, and 10 years in A group was 92.3, 85.4, and 85.4%, respectively. Freedom from postoperative aPA restenosis at 1, 5, and 10 years in B group was 75.2, 63.3, and 57.5%, respectively (log-rank, P = 0.038). Multivariate Cox proportional hazards regression analysis showed that smaller innate Z-score of aPA and angioplasty with autologous tissue were independent risk factors for aPA restenosis. Freedom from reintervention for aPA restenosis at 1, 5, and 10 years in A group was 97.1, 93.0, and 93.0%, respectively. Freedom from reintervention for aPA restenosis at 1, 5, and 10 years in B group was 95.7, 85.3, and 77.5%, respectively (log-rank, P = 0.235). Surgical reimplantation in AOPA patients has resulted in favorable long-term outcomes. Direct anastomosis is superior to angioplasty with autologous tissue in avoiding late aPA restenosis. Intrinsic dysplasia of aPA also increases the incidence of stenosis. However, the type of reimplantation did not significantly affect late reintervention.
Indexed as
Identifiers
40423720What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.